[Progress in the symptomatic treatment of bronchial asthma].
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000336:Aerosols; D000818:Animals; D000962:Antimalarials / Q000008:administration & dosage; D001249:Asthma / Q000188:drug therapy* / Q000628:therapy; D002738:Chloroquine / Q000008:administration & dosage; D004049:Diethylcarbamazine / Q000008:administration & dosage; D006168:Guinea Pigs; D006801:Humans; D007666:Khellin / Q000008:administration & dosage; D008134:Long-Term Care; D012129:Respiratory Function Tests; D012138:Respiratory Therapy; D013566:Sympathomimetics / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D013997:Time Factors
D000318:Adrenergic beta-Agonists; D000336:Aerosols; D000962:Antimalarials; D013566:Sympathomimetics; D007666:Khellin; D002738:Chloroquine; D004049:Diethylcarbamazine
Fortschritte der symptomatischen Therapie des Asthma bronchiale.